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Abstract
Background: Recently, long noncoding RNAs have emerged as pivotal molecules for the regulation of coding genes’
expression. These molecules might result from antisense transcription of functional genes originating natural antisense
transcripts (NATs) or from transcriptional active pseudogenes. TBCA interacts with b-tubulin and is involved in the folding
and dimerization of new tubulin heterodimers, the building blocks of microtubules.
Methodology/Principal Findings: We found that the mouse genome contains two structurally distinct Tbca genes located
in chromosomes 13 (Tbca13) and 16 (Tbca16). Interestingly, the two Tbca genes albeit ubiquitously expressed, present
differential expression during mouse testis maturation. In fact, as testis maturation progresses Tbca13 mRNA levels increase
progressively, while Tbca16 mRNA levels decrease. This suggests a regulatory mechanism between the two genes and
prompted us to investigate the presence of the two proteins. However, using tandem mass spectrometry we were unable
to identify the TBCA16 protein in testis extracts even in those corresponding to the maturation step with the highest levels
of Tbca16 transcripts. These puzzling results led us to re-analyze the expression of Tbca16. We then detected that Tbca16
transcription produces sense and natural antisense transcripts. Strikingly, the specific depletion by RNAi of these transcripts
leads to an increase of Tbca13 transcript levels in a mouse spermatocyte cell line.
Conclusions/Significance: Our results demonstrate that Tbca13 mRNA levels are post-transcriptionally regulated by the
sense and natural antisense Tbca16 mRNA levels. We propose that this regulatory mechanism operates during
spermatogenesis, a process that involves microtubule rearrangements, the assembly of specific microtubule structures and
requires critical TBCA levels.
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Introduction
Long noncoding RNAs have emerged as pivotal molecules for
the regulation of coding genes’ expression [1,2,3].
One of the classes of regulatory noncoding RNAs is that of
natural antisense transcripts (NATs) that are defined as endoge-
nous RNA molecules at least partially complementary to
transcripts of established function [4]. Using genome wide
approaches it became evident that antisense transcription is a
widespread event throughout evolution [5], and that mammalian
genomes encode a large number of NATs [6,7,8].
NATs can be classified in two major groups: cis-encoded, being
produced from the same locus as their sense counterpart and trans-
encoded being transcribed from different loci [9]. Trans-NATs also
differ from cis-NATs by presenting inexact sequence complemen-
tarity with their sense counterpart transcript. In prokaryotes,
NATs have been implicated in the control of plasmid replication,
bacteriophage development and gene expression regulation
[10,11]. In eukaryotes, they are involved in transcription
regulation [12–16], alternative splicing [17,18], RNA stability
and translation regulation, [15,19–21], X-chromosome inactiva-
tion [22,23], histone modification and DNA methylation in
genomic imprinting [24–26]. The different biological functions
carried out by NATs seem to involve a variety of distinct
transcriptional and post-transcriptional regulatory mechanisms,
such as recruitment/targeting of chromatin complexes, transcrip-
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tional interference, RNA masking, RNA editing, and RNA
interference (RNAi) [5,27,28].
There are also growing evidences that long noncoding RNAs
molecules might be produced by transcriptional active pseudo-
genes [29]. Traditionally, pseudogenes are considered as copies of
protein-coding genes that have lost the ability to produce
functional proteins [30] and it is well accepted that they can be
created by diverse processes, like: (1) spontaneous mutations,
preventing transcription of the gene or translation of the protein
[31]; (2) duplication, in which pseudogenes are originated via
tandem duplication or uneven crossing-over leading to the loss of
promoters or enhancers or the appearance of crippling mutations
such as frame shifts or premature stop codons [30] and (3)
retrotransposition; the mRNA transcript is reverse-transcribed and
integrated into the genome at a new location originating
retrotransposed or processed pseudogenes [32,33].
Recently, it was demonstrated that pseudogene transcripts can
be processed into small interfering RNAs (siRNA) with the ability
to repress gene expression in mouse oocytes [34,35]. These
siRNAs are derived either from pseudogenes with internal
secondary structures, or from dsRNAs resulting from sense and
antisense transcripts pairing. These mechanisms seem also to
operate in plant genomes, for example in rice, in which a small
number of pseudogenes are transcribed and processed into
siRNAs, after pairing with the coding gene or a paralogous
pseudogene transcript [36].
The regulatory role of NATS and transcribed pseudogenes
seems to have a wide impact in testis where these RNAs are highly
abundant [37]. The production of functional gametes in testis is a
complex developmental and maturation process that requires, for
example rearrangements of the microtubule cytoskeleton and the
assembly of specialized microtubule structures [38]. Microtubules
are polarized and dynamic polymers of a/b-tubulin heterodimers,
that are involved in a great variety of cellular functions, e.g. the
intracellular spatial organization, generation of cell polarity,
intracellular transport, cell division, cell signalling and cell motility
[39].
TBCA interacts with b-tubulin and together with other
molecular chaperones and tubulin cofactors (TBCs, A–E) is
involved in the maturation of new tubulin heterodimers [40–42].
Although not essential for tubulin heterodimer formation in vitro
[42], TBCA knockdown by RNAi in human cell lines, leads to
decreased amounts of a- and b-tubulin levels, subtle alterations in
the microtubule cytoskeleton, G1 cell cycle arrest and cell death
[43]. Previous studies focused in Tbca expression have shown that
it is constitutively expressed in different mouse tissues but more
abundantly in testis where it is also progressively up-regulated
during the first spermatogenesis [44].
Here we report that the mouse genome presents two Tbca genes,
one localized in chromosome 13 and one in chromosome 16 (Tbca16
- previously unidentified). The study of the tissue-specific expression
of the Tbca13 and Tbca16 genes showed them to be ubiquitously
expressed. Furthermore, during spermatogenesis, Tbca13 and Tbca16
present opposite patterns of expression. We also demonstrate that
Tbca16 codes for a sense transcript and a cis-NAT in vivo, during
spermatogenesis, and these transcripts are involved in the regulation
of Tbca13 expression in a mouse spermatocyte cell line.
Results
The mouse genome contains two Tbca genes localized in
chromosomes 13 and 16
TBCA is a b-tubulin binding protein that participates in the
tubulin folding pathway. In vitro, TBCA is not critical for tubulin
folding but enhances b-tubulin dimerization [41]. On the other
hand, our previous studies of TBCA loss-of-function showed that
human TBCA is an essential gene in human cell lines, its depletion
causing a decrease in a- and b-tubulin levels [43]. These data
indicate that TBCA is important for microtubule formation and
consequently for microtubule-dependent functions. This is also
hinted by the fact that TBCA is highly expressed in testis and is
up-regulated during spermatogenesis, a process in which the
microtubule cytoskeleton is preponderant. These observations lead
us to go further in the functional characterization of Tbca in vivo. In
the course of these studies we have detected that the mouse
genome possess two Tbca genes, one previously described localized
in chromosome 13 (Tbca13) and an uncharacterized Tbca gene in
chromosome 16 (Tbca16). Tbca16 is localized inside the intron 3–4
of the Adenylatecyclase 9 gene (Adcy9) being its putative coding
sequence in the same strand as the Adcy9 exons. The nucleotide
sequence analysis of the two Tbca genes revealed that their
structure is different. The Tbca13 gene presents its coding region
interrupted by three introns. In contrast the Tbca16 gene is
intronless. A comparison between the nucleotide sequences of both
genes revealed that their coding sequences present a high degree of
identity (98%) with only 7 nucleotide substitutions (Fig. 1A). This
high degree of nucleotide sequence identity extends to the 59and
39-noncoding regions. For example, upstream of the ATG codon,
the two genes present indistinguishable nucleotide sequences over
30 nucleotides and present an identity of 97% over 174
nucleotides of the 39-non-coding region (Fig. 1A). As a
consequence, the two Tbca genes encode two putative closely
related proteins differing only in 4 aminoacid residues (Fig. 1B).
These substitutions may not have significant impact in the 3D
structure of the putative TBCA16 protein, given the similarity of
their predicted 3D structures (Fig. 1C). Even so, important
charged residues for putative protein interactions would disappear
in the hypothetical TBCA16 protein.
Tbca13 and Tbca16 present distinct patterns of
expression during mouse testis maturation
Previous studies, where no distinction between the two specific
Tbca transcripts was made, have shown that Tbca was more
abundantly expressed in testis than other adult tissues. In fact, Tbca
was progressively up-regulated from the onset of meiosis through-
out spermatogenesis, being more abundant in differentiating
spermatids [44]. This Tbca expression pattern was proposed to
be associated to microtubule cytoskeleton changes and b-tubulin
processing throughout spermatogenesis rather than to meiosis
[44]. The existence of two mouse genes encoding two distinct
TBCA isotypes prompted us to investigate if both genes were
transcribed and presented tissue-specific regulation. Therefore, we
extracted total RNA from different mouse organs and performed
RT-PCR using specific forward primers for each Tbca gene. Each
specific primer was designed to hybridize with a sequence located
about 66 bp upstream of the start codon at 59-UTR (59-
untranslated region see Fig. 1A, P-specific Tbca16) of the two
Tbca genes, where these sequences started to diverge. Before any
analysis, a search of each of these specific primers throughout the
mice genome sequence was performed. This BLAST analysis
showed these primers to be specific for the 59-UTR of each Tbca
gene. The reverse primer was the same for both genes and
hybridizes with a conserved sequence localized close to the stop
codon (see Fig. 1A. P-Tbca reverse). The obtained amplification
products were sequenced and this analysis showed that these
products correspond to the amplification of the expected
transcripts from the gene under analysis. To exclude the possibility
of genomic DNA contamination affecting these results, all RNA
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samples were treated with DNase I and tested by PCR using
primers specific for genomic DNA, prior to cDNA synthesis. The
obtained results showed that Tbca13, as well as Tbca16 are both
transcribed at different levels in all the mouse organs analyzed
(Fig. 2). This analysis also revealed that, contrary to Tbca16,
Tbca13 is highly expressed in adult testis in comparison with the
other organs. This shows that the high TBCA levels previously
observed in mature testis [44] correspond to Tbca13. Given what
was previously described we decided to analyze also the expression
of Tbca13 and Tbca16 genes during the different stages of the
mouse first spermatogenesis, which occurs during the first post-
natal month in parallel with testis maturation. Consequently, we
extracted total RNAs from mouse testis at different post-natal days
(14, 18 and 25 days) and analyzed the expression of both Tbca
genes by RT-PCR using the primers already described (Fig. 3).
With this analysis we observed that Tbca13 and Tbca16 genes
present opposite expression patterns during the process of testis
maturation. In fact, Tbca13 mRNA levels increase progressively,
while Tbca16 mRNA levels decrease. Taken together, these data
indicate that the two genes are regulated differentially and suggest
that the products encoded by them might play distinct roles during
testis development.
Tbca16 is transcribed as a sense and an antisense RNA
The fact that both Tbca13 and Tbca16 genes present distinct
expression patterns during testis development led us to investigate
if the steady-state levels of the respective encoded proteins
accompanied the levels of the specific transcripts. In fact, the
production of an mRNA encoded by the Tbca16 gene did not
imply by itself the existence of a TBCA16 protein. Given the fact
that the TBCA13 and TBCA16 predicted proteins differ only in 4
amino-acid residues it would be difficult to produce a specific
antibody capable of distinguishing them. To overcome this
difficulty and to identify the TBCA16 protein in vivo we cloned
the coding regions of Tbca13 and Tbca16 in a bacterial expression
vector and expressed them in E. coli. The recombinant proteins
were purified and analyzed by electrophoresis on a Tricine-SDS-
PAGE in parallel with a 14 post-natal days testis protein extract.
This testis developmental stage was chosen since it corresponds to
the stage with the highest Tbca16 mRNA levels (Fig. 3). This
analysis was followed by western blot using an antibody against
human TBCA that recognized the mouse TBCA13 and TBCA16
proteins produced in bacteria (Fig. 4). Interestingly, although both
proteins present the same predicted molecular mass, under the
conditions used, TBCA16 migrated faster than TBCA13 (Fig. 4).
Thus, it was possible to distinguish the two proteins due to their
distinct mobility in Tricine-SDS-PAGE. However, in 14 post-natal
days testis protein extracts the antibody only recognized a unique
protein band presenting a migration behavior similar to that of
TBCA13 (Fig. 4). This suggested that, although these protein
extracts corresponded to the testis maturation stage were Tbca16 is
up-regulated, they only appeared to contain the protein product of
the Tbca13 gene. To confirm this result we first re-analyzed protein
extracts from 14 days old testis in parallel with purified TBCA13
and TBCA16 proteins in a Tricine-SDS-PAGE followed by
Coomassie blue staining. In this analysis the purified TBCA13 and
16 proteins were used as migration references to allow the
identification of the region where both TBCA proteins should be
present in the analyzed testis protein extracts. Subsequently, this
region was excised from the gel and the proteins presented there
were identified by tandem mass spectrometry. To make sure that
this analysis was able to distinguish between the two TBCA
proteins, purified TBCA13 and 16 proteins were previously
analyzed. The obtained data revealed that the distinction between
TBCA13 and TBCA16 proteins by tandem mass spectrometry
was possible due to the aminoacid substitutions occurring in
position 77 and 88. In fact, the theoretical complete trypsin
hydrolysis of the two TBCA proteins originated two distinct
peptides with different molecular masses (TBCA13:-
LEAAYTDLQQILESEK and TBCA16:QLEAAYTGLQQILE-
SEK). Since the identification of the proteins analyzed by tandem
mass spectrometry requires a search in protein databases to
identify the specific protein profile we have updated them by
introducing the corresponding TBCA16 data. Noteworthy, with
this approach we were only able to detect the specific peptide
corresponding to the TBCA13 protein in protein extracts of 14
days post-natal mouse testis (Fig. 4). The LEAAYTDLQQILE-
SEK peptide was identified with a peptide score of 80, clearly
above the identity threshold (51) determined by the search
algorithm, thus confirming the unambiguous identification of
TBCA13 in the sample. Although the peptide QLEAAYTGLQ-
QILESEK was not detected, the possibility of minimum amounts
of TBCA16 being synthesized cannot be completely excluded.
Furthermore this result is in agreement with the ones obtained by
western blot (Fig. 4) indicating that the TBCA16 protein is most
probably not being synthesized in this testis maturation stage.
These intriguing results associated with the observation that
Tbca16 presents an opposite expression pattern to that of Tbca13
lead us to put forward the hypothesis that Tbca16 transcripts could
play a regulatory role in the expression of the Tbca13 gene.
Moreover, there are growing evidences in the literature showing
that the expression of genes can be regulated by non-coding
Figure 1. Comparison of Tbca13 and Tbca16 sequences and 3D Model Structure of TBCA16 and TBCA13. Comparison between
nucleotide sequences of Tbca16 and Tbca13 (A). The alignment shows 7 differences inside the coding region (the different nucleotides are in red,
start and stop codons are inside a red dashed box). The regions where the different primers/shRNAs were designed are indicated. (B) Comparison of
the aminoacid sequences of the putative TBCA16 and theTBCA13 protein, aminoacids are colored according to their polarity. The 4 differences are
signaled with a black dot above the respective aminoacid (B). The sequences in (A) and (B) were done using the CLC Sequence Viewer 6.5.3 Program.
(C) TBCA13 and TBCA16 3D models obtained using the program PyMOL [55] program (C). The aminoacid differences are indicated in the table,
accordingly to the aminoacid position.
doi:10.1371/journal.pone.0042536.g001
Figure 2. Study of Tbca16 and Tbca13expression in different
mouse tissues by RT-PCR. RT-PCR analysis of Tbca13 and Tbca16
transcript levels using total RNA samples extracted from different
mouse tissues (3 mice, 25 post-natal days old, were used in this
analysis). In contrast with Tbca13 expression, Tbca16 is not highly
expressed in testis. The Hprt expression was analyzed as an endogenous
control.
doi:10.1371/journal.pone.0042536.g002
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Figure 3. Study of Tbca16 and Tbca13 expression pattern during mouse spermatogenesis. Total RNA was obtained from mouse testis at
different stages of maturation (3 sets of 14, 18 and 25 post-natal days old mice were used in this study). The Tbca16 and Tbca13 expression levels
were analyzed by semi-quantitative RT-PCR and normalized by the expression of Hprt. During spermatogenesis the steady-state levels of Tbca13
mRNA increase whereas a decrease in the steady-state levels of Tbca16 mRNA is observed. Normalized cDNA levels are expressed as a percentage of
maximal value (100%) for the 14 post-natal day. The p values were determined in comparison to the 14 post-natal days. The graphic bars are the
mean6s.d. (error bars) of three independent assays. Statistical significance was calculated using a t-test.
doi:10.1371/journal.pone.0042536.g003
Figure 4. TBCA16 protein is absent in early stages of mouse spermatogenesis. Protein extracts from mouse testis in early stages of
spermatogenesis (14 post-natal days – PND14) and recombinant TBCA13 and TBCA16 proteins produced and purified from bacteria were analyzed by
16.5% (w/v) Tricine–SDS–PAGE followed by western blot with a specific polyclonal antibody directed to TBCA. Note that this antibody recognizes
both recombinant proteins. Under these conditions, TBCA13 and TBCA16 proteins have distinct motilities. The approximate molecular mass of the
proteins is indicated at the left side of the panels. The regions around the 14 kDa marked by dashed squares were excised and proteins present in
these regions were analyzed by electrospray mass spectrometry (MS/MS). The analyses lead to the identification of the TBCA13 specific peptide
R.LEAAYTDLQQILESEK.D (the specific aminoacid is underlined). No TBCA16 specific peptides were identified (see table).
doi:10.1371/journal.pone.0042536.g004
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antisense mRNAs, some transcribed from their pseudogenes [29].
In our previous strategy to analyze the specific expression of
Tbca13 and Tbca16 genes by RT-PCR (Fig. 2 and 3) the cDNAs
were synthesized using a primer d(T) to hybridize with the poly(A)+
tail, which did not allow us to account for the orientation of the
RNAs under study. To address this issue we set up an RT-PCR
experiment in which the cDNA would be produced using a
sequence-specific primer complementary to the Tbca16 mRNA in
a sense (P-specific sense) and antisense orientation (P-specific
antisense) (see Fig. 1A). Subsequently, we used DNase-treated
RNAs from 14 post-natal days mouse testis to synthesize cDNA
either using the specific sense- and antisense-Tbca16 primers, or
the universal d(T) primer. Next, Tbca16 transcripts were amplified
by PCR using the specific primers for Tbca16 (Fig. 1A, P-specific
Tbca16) and using the following templates: (i) DNase treated RNA
used in the cDNA synthesis; (ii) a cDNA synthesized using the d(T)
primer and (iii) cDNAs synthesized with the specific Tbca16 primer
in sense or antisense orientation. The results presented in Fig. 5
show that there is no amplification when the RNA sample is used
as a template showing that the RNA sample was not contaminated
with genomic DNA. On the other hand, for each cDNA sample
used, a single band with the expected size for the Tbca16 transcript
was detected (Fig. 5). These PCR products were sequenced and
their nucleotide sequence was an exact match to the sequence of
Tbca16 transcripts leading to the conclusion that the Tbca16 gene is
transcribed both in a sense and an anti-sense (anti-Tbca16)
orientation.
The existence of two distinctly oriented transcripts from Tbca16
gene is noteworthy. In fact due to their perfect complementary
sequence it is conceivable that they can be paired in vivo,
originating long double strand RNA molecules. These molecules
have been described to be precursors for the interference RNA
machinery leading to the formation of siRNA duplexes [34,35]. In
this context we put forward the hypothesis that the Tbca16 gene is
a regulator of the Tbca13 causing it’s silencing by originating a
population of sequence-specific siRNAs for Tbca13 mRNAs.
The steady-state levels of the Tbca16 transcripts affect
the levels of Tbca13 mRNA
To investigate the putative regulatory role of the sense and anti-
sense Tbca16 in the levels of the Tbca13 transcripts in vivo, we
decided to perform RNAi experiments. For this purpose we
designed a shRNA targeting specifically the sense and anti-sense
Tbca16 transcripts (see fig. 1A, Tbca16 shRNA). In this experiment
we also designed a shRNA targeting both Tbca genes (Tbca
shRNA). Unfortunately, specific shRNAs targeting the Tbca13
transcripts were not effective in the knockdown process.
Taking into consideration the expression patterns of the two
Tbca genes during testis maturation we decided to study the effects
of the specific Tbca16 knockdown in the GC-2spd(ts)-spermatocyte
mouse cell line (GC-2 cells). As a control, GC-2 cells were
transfected with a plasmid encoding a non-target shRNA to check
for general non-specific effects associated with shRNA delivery
and to confirm the sequence specificity of the silencing effect
(negative control). Additionally, GC-2 cells were transfected with
the Tbca shRNA coding plasmid to target the transcripts of both
Tbca genes (13+16) and with a plasmid coding for the Tbca16
shRNA specifically targeting the transcripts of the Tbca16 gene. At
48 h post-transfection total RNAs were extracted from GC-2 cells
expressing the non-target shRNA, the Tbca(13+16) shRNA, or the
Tbca16shRNA which were then analyzed by RT-PCR. Semi-
quantitative RT-PCR analysis showed a decrease in the steady-
state levels of Tbca16 mRNA in Tbca(13+16) and in Tbca16shRNA
expressing cells, in comparison with those found in control cells
expressing the non-target shRNA (Fig. 6). Also, a decrease in the
Tbca13 mRNA steady-state levels was observed in cells transfected
with the Tbca(13+16) shRNA. Remarkably, in cells expressing the
Tbca16 shRNA we observed an increase in Tbca13 mRNA steady-
state levels to levels higher than those found in cells expressing the
non-target shRNA. The difference observed in Tbca16 mRNA
decrease levels in cells transfected with Tbca(13+16) shRNA and
Tbca16 shRNA could be explained by different silencing efficien-
cies of both interfering RNAs. Also, when GC-2 cells are
transfected with a recombinant plasmid (see Material and
Methods) to over-express the antiTbca16 transcript we observed
an increase in the antiTbca16 transcript levels. The observed
increase is accompanied by a decrease of about 20% on the
Tbca13 transcript levels (Fig. S1).
To investigate if the alterations in the transcript levels caused by
RNAi depletion of Tbca16 transcripts have an impact in TBCA
protein levels we have also performed a western blot analysis of
soluble protein extracts isolated from GC-2 cells transfected either
with Tbca(13+16) shRNA or Tbca16 shRNA for 48 h (Fig. S2). The
results showed a slight decrease in the steady state levels of the
TBCA protein when GC-2 cells are transfected with the
Tbca(13+16) shRNA, whereas an increase of TBCA protein levels
was detected when cells were transfected with Tbca16 shRNA for
the same period of time (Fig. S2) which shows again the regulatory
role of the Tbca16 RNAs.
All together the results strongly support our hypothesis that the
Tbca16 transcripts are involved in the post-transcriptional regula-
tion of the Tbca13 gene expression. Moreover, these results can
explain the opposite expression patterns of the two Tbca genes
during spermatogenesis.
Discussion
Some pseudogenes are transcriptionally active producing
noncoding RNAs that are able to regulate the expression of
functional genes by a variety of mechanisms [29]. NATs are
noncoding regulatory RNAs that occur ubiquitously in prokary-
otes and eukaryotes carrying out critical functions. The analysis of
the validated NAT lists showed that many are transcribed from
genes involved in development or associated with human diseases
[27].
In this work we identified a mouse intronless Tbca gene localized
in chromosome 16 (Tbca16) that is transcribed in both orientations
Figure 5. Tbca16 gene codes for a sense and for an antisense
transcript. Total RNA was extracted from 14 post-natal days mouse
testis and analyzed by RT-PCR. For the cDNA synthesis oligodT (cDNA-
oligodT), Tbca16 sequence-specific primer for antisense orientation
(cDNA-antisense) or Tbca16 sequence-specific primer for sense
orientation (cDNA-sense) were used. The presence of the Tbca16
transcript was analyzed by PCR using specific primers. In every case a
single band with the expected size was detected. A PCR performed only
with RNA (RNA) as the template was done as a control to detect any
residual amplification from a DNA genomic contamination.
doi:10.1371/journal.pone.0042536.g005
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originating sense and anti-sense transcripts. This gene is closely
related to the mouse Tbca13 localized in chromosome 13 that has
three introns and encodes TBCA, a protein involved in tubulin
heterodimer maturation. In fact, both genes share 97% of
nucleotide sequence identity in their coding regions and are
highly identical throughout part of their 59and 39non-coding
regions. Since the Tbca16 gene is transcribed in the sense
orientation it may encode a TBCA16 protein differing from the
TBCA13 protein in only 4 amino-acid residues. Interestingly, we
observed that the steady-state levels of Tbca16 transcripts (sense
and anti-sense) decrease during testis maturation while the Tbca13
transcript levels increase. These observations led us to investigate
the presence of the TBCA16 protein in protein testis extracts
corresponding to the developmental stages where Tbca16 was up-
regulated during testis maturation. However, all attempts to
identify the putative TBCA16 protein, either by western blot or
mass spectrometry, have failed suggesting that most probably the
TBCA16 protein is not translated or is very unstable. These
unexpected observations led us to reassess the role of the Tbca16
gene.
Taking into account the analysis of the structure and nucleotide
sequence features of the Tbca16 gene, in comparison with those of
the Tbca13 gene, it is plausible that Tbca16 gene could have been
generated by a retrotransposition event of processed Tbca13
transcripts that in this case would be the parental gene. Indeed,
according to a study focused in the origin of human retro-
transposed mRNAs [45] the Tbca13 mRNA characteristics fit
extremely well in the class of mRNAs that are prone to create
processed pseudogenes. Moreover, it is also generally accepted
that germline expression is crucial for the inheritance of processed
pseudogenes and the Tbca13 gene is highly expressed in testis.
Moreover, if this hypothesis is true than the event/s that led to the
creation of the mouse Tbca16 pseudogene most probably occurred
before the divergence at least of the mammals, because Tbca16
homologous intronless genes were found in the rat (chromosome
7), human (chromosome X) and chimpanzee (chromosome X)
genomes. Also, a close analysis of the human TbcaX nucleotide
sequence shows that the coding region of this gene is interrupted
by a stop codon (TAA) in position 64, supporting the idea that this
gene if transcribed and translated produces a truncated, probably
non-functional protein and therefore is probably a pseudogene.
The conserved presence of pseudogenes in the genome of related
species has been used as an argument to support the idea that
conserved pseudogenes have been maintained due to having a
functional role [29].
Furthermore, the opposite pattern of expression of Tbca16 and
Tbca13 during testis maturation suggested that there is a regulatory
mechanism between Tbca16 and Tbca13 transcript levels. This
hypothesis is strongly supported by the fact that the specific
decrease of Tbca16 transcripts by RNAi in the spermatocyte mouse
cell line GC-2 lead to an increase in Tbca13 transcripts. In
accordance the overexpression of these transcripts causes a
decrease in Tbca13 transcripts (Fig. S1). Consequently, Tbca16
transcripts may play a critical role in the post-transcriptional
regulation of Tbca13 gene expression. In fact, the depletion of
Tbca16 transcripts from GC-2 cells by RNAi causes an increase in
TBCA protein levels (Fig. S2) Although, the exact mechanism
behind this regulation remains to be elucidated, the fact that the
two Tbca genes share a high degree of nucleotide sequence identity
suggest that this may occur by a mechanism of RNA interference
[34,35]. In this view the antisense-Tbca16 RNA would pair with
the sense-Tbca16 transcript and also with Tbca13 mRNA forming
long double-stranded RNA molecules in vivo, that then would be
processed by the endogenous RNAi machinery originating specific
siRNAs that would interfere with Tbca13 transcripts. In agreement
with this idea, recent studies in plants and mouse identified endo-
siRNAs involved in the regulation of gene expression and that
were derived from sense-antisense RNA pairs (pseudogene-
pseudogene and pseudogene with 90% homology-coding mRNA)
produced through the RNA interference pathway [34,35,46].
It has been proposed, based on large scale genomic approaches,
that NATs overexpression in testis is a general phenomenon and
not restricted to specific genes [47,48]. Moreover, most of the
transcribed pseudogenes are expressed in testis [37]. The
biological significance of these events in testis is far from being
understood, however it is tempting to propose that these
regulatory mechanisms are an additional guarantee for the correct
development and specific function of this highly differentiated
organ that originates the germ-line. Accordingly, the Tbca13 and
Tbca16 genes opposite expression pattern during testis maturation,
associated to the fact that Tbca13 mRNA protein levels, are
affected by the amount of the Tbca16 transcripts in a spermatocyte
mouse cell line, strongly support the idea that the specific
regulation between the two types of transcripts is important for
organ function/maturation. Spermatogenesis is a very complex
developmental process that requires precise microtubule cytoskel-
eton remodeling originating complex microtubule structures like
the manchette and the flagellum of the sperm [38]. Therefore, it is
Figure 6. Tbca16 knockdown increases the steady-state levels
of Tbca13 RNA in GC-2spd(ts)-spermatocyte mouse cell line.
After 48 h of transfection, total RNA was extracted from GC-2spd(ts)
cells expressing non-target shRNA, TbcashRNA(knockdownTb-
ca13+Tbca16) or Tbca16shRNA (to knockdown exclusively the Tbca16
RNA). Semi-quantitative RT-PCR analysis showed a decrease in the
steady-state levels of Tbca13 and Tbca16 mRNAs in Tbca shRNA
expressing cells in comparison to those in cells expressing non-target
shRNA. However, in cells expressing Tbca16 shRNA the steady-state
levels of Tbca16 mRNA decrease whereas those of Tbca13 mRNA
increase. Normalized cDNA is expressed as a percentage of maximal
value (100%). *p,0,05 compared with control. The graphic bars are the
mean6s.d. (error bars) of three independent assays. Values were
standardized with those of Hprt cDNA. Statistical significance was
calculated using a t-test.
doi:10.1371/journal.pone.0042536.g006
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conceivable that TBCA plays an important role during this process
and that the fine-tuned regulation of TBCA levels is critical and
achieved by a post-transcriptional regulation mechanism involving
the expression of Tbca16 transcripts.
Materials and Methods
Ethics statement
In total, 12 Swiss-Webster mice were used in this study. To
extract RNA from testis of different ages, 3 sets of 3 mice, each set
with one mouse of 14, 18 and 25 post-natal days old were used
(figure 3). From the adult mice (25 post-natal days) we also
extracted RNA from different organs (figure 2). Then, 3 additional
mice with 14 post-natal days old were used to obtain protein
extracts from testis for the mass spectrometry analysis. They were
killed according to PHS policy and the U.S. National Institutes of
Health guidelines. The animal experiments were approved by the
ethical committee from ‘‘Universidad da Cantabria’’, Spain. The
approval documents are signed by the president of the ethical
committee, Professor Miguel Lagarfa Coscojuela, and were
uploaded in the ‘‘attach files section’’ together with the manuscript
(as a JPEG files).
Cell culture
GC-2spd(ts) cell line (mouse spermatocyte; SV40 large T
antigen transfected; these cells are arrested at a premeiotic stage
– this cell line was purchased from ATCC-LGC [49]) was cultured
in a 5% CO2 humidified atmosphere at 37uC as exponentially
growing sub-confluent monolayers in Dulbecco’s modified Eagle’s
medium (DMEM) with Glutamax (Invitrogen), supplemented with
10% fetal calf serum (Invitrogen).
RNA extraction and RT-PCR expression analysis
Total RNA was extracted from mice organs and also from GC-
2 cell line using the RNeasy mini-kit (Qiagen), according to the
manufacturer’s protocol. The RNA was treated with DNase I
(Invitrogen) and reverse transcribed using SuperScript II (Invitro-
gen) and an oligo(dT)12–18 primer (Invitrogen) or using specific
primers for Tbca16: sense (59-CACAGCAGTGGCCGAAAT-39)
and antisense orientation (59-GGATGAACACTGATTGTG-39).
The RT-PCR procedure was adapted from [50]. The amount
of cDNA in each sample was first normalized, after non-saturing
PCR, for Hprt (hypoxanthine guanine phosphoribosyltransferase
1-standard internal control) transcripts. The identity of PCR
products was confirmed by sequencing. Semi-quantitative RT-
PCR expression analysis was performed using the following
forward and reverse primers: mouse Hprt (Accession number –
NM_013556) - 59-GGACAGGACTGAAAGACTTG-39 and 59-
CACAAACGTGATTACAATCCC-39; mouse Tbca13 (Accession
number – NM_009321) - 59-CACCGCCCCTTCTGCGC-39 and
59-GACCCCAGGATTTAATGC-39; mouse Tbca16 - 59-GGAT-
GAACACTGATTGTG-39 and 59-GACCCCAGGATT-
TAATGC-39. To amplify Tbca13 and Tbca16, from different
adult mice tissues (25 post-natal days), we have performed 36
cycles in the PCR amplification process in order to guarantee a
detectable amplification product even in organs where Tbca13 and
Tbca16 was less/vestigial expressed. Using these PCR conditions
the expression of Tbca13 in testis corresponds to a saturated band
that impairs any quantification. To avoid any saturation and
allowing quantification the PCR reaction conditions were distinct
in the experiments concerning the study of the expression of
Tbca13 and Tbca16 during testis development. Thus we have
performed 28 cycles for Hprt (internal control), 30 cycles for
Tbca13 and 36 cycles for Tbca16 in the PCR amplification process.
Protein extracts, TBCA purification and mass
spectrometric analysis
cDNAs from Tbca13 and Tbca16 were cloned into the bacteria
expressing vectors pET3a (Novagen). Recombinant TBCA13 and
TBCA16 proteins were produced and purified from Escherichia
coli BL21:DE3 cultures as previously described [51]. The
recombinant proteins were used to optimize the tandem electro-
spray mass spectrometry conditions.
Mouse testis protein extracts (from 14 post-natal days) and GC-
2 transfected cells with non-target siRNA, with Tbca(13+16)
shRNA or Tbca16 shRNA during 48 h were performed accord-
ingly to Nolasco et al., 2005 [43] and analyzed on a 16.5% (w/v)
Tricine–SDS–PAGE [52] and the band correspondent to the
TBCA expected region was excised manually from the gel and
analyzed by tandem mass spectrometry. For peptide identification
MASCOT (Matrix Science) search engine was used and peptide
score threshold indicating identity or extensive homology was 51
(p,0.05 for an observed match to be a random event).
Western blot analysis
Protein extracts were separated on a 16.5% (w/v) Tricine–
SDS–PAGE [52]. Westerns blots were performed using the rabbit
polyclonal sera against TBCA (1:5000) [53] and Anti-Actin (20–
33) antibody produced in rabbit (1:2000) (Sigma). Secondary
antibody against rabbit (Jackson Immuno Research) was used at
1:4000. The immunostaining was carried out using the ECL
technique (GE Healthcare). The molecular mass markers used
were purchased from GE Healthcare.
Construction of RNAi vectors, cloning of antiTbca16 and
transfection
pSUPER, vector used for expression of short interfering RNAs
(shRNAs), was purchased from OligoEngine (Seattle, WA, USA)
and the constructs were done as described previously [54]. To
construct the pSUPER_Tbca_shRNA, pSUPER_Tbca16_shRNA
and pSUPER_Non Target_shRNA vectors pairs of 64-nt oligo-
nucleotides (Sigma), forward and reverse, each containing a
unique 19-nt sequence derived from within the target mRNA
transcripts (see below), was annealed and ligated between the
BglII/HindIII sites of the pSUPER. Within the 64-nt oligomers,
the 19-nt target sequence appears in both sense and anti-sense
orientation (bold), separated by a 9-nt spacer sequence (under-
lined).
- pSUPER_Tbca_shRNA oligonucleotides: 59GATCTCC-
GACCGGAGTAGTGAGGCGATTCAAGAGATCGCCTCA-
CTACTCCGGTCTTTTTGGAAA39 and 59AGCTTTTCCA-
AAAAGACCGGAGTAGTGAGGCGATCTCTTGAATCGC-
CTCACTACTCCGGTCGGA39.
- pSUPER_Tbca16_shRNAoligonucleotides:
59GATCTCCAGGATGAACACTGATTGTGTTCAAGAG-
ACACAATCAGTGTTCATCCTTTTTTGGAAA39 and 59A-
GCTTTTCCAAAAAAGGATGAACACTGATTGTGTCTCT-
TGAACACAATCAGTGTTCATCCTGGA39.
- pSUPER_NonTarget_shRNA oligonucleotides:
59GATCTCCGATCAAGACCGAACAATCCTTCAAGAG-
AGGATTGTTCGGTCTTGATCTTTTTGGAAA39 and
59AGCTTTTCCAAAAAGATCAAGACCGAACA ATCCTC-
TCTTGAAGGATTGTTCGGTCTTGATCGGA39.
pcDNA3, vector used to overexpress the antiTbca16 cDNA, was
purchased from Invitrogen. To construct the recombinant
pcDNA3 antiTbca16 we amplified antiTbca16 using the primers
previously described at the Material and Methods in the ‘‘RNA
extraction and RT-PCR expression analysis’’ section but contain-
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ing at their 59 ends sequences for restriction enzymes: HindIII (for
the reverse primer) and BamHI (for the forward primer). Using
these enzymes antiTbca16 was cloned under the promoter region
of the vector which will upon transcription will produce
antiTbca16 transcripts.Transfections were performed with lipofec-
tamine 2000 (Invitrogen) as specified by the manufacturer. At 18 h
prior to transfection, 86104 cells were seeded per well for a 6-well
plate.
Statistical analysis
The experiments were performed at least three times and the
results were expressed as means 6 S.D. Differences between the
data were tested for statistical significance by t-test. P values less
than 0.05 were considered statistically significant.
Supporting Information
Figure S1 AntiTbca16 overexpression decreases the
steady-state levels of Tbca13 RNA in GC-2spd(ts)-
spermatocyte mouse cell line. After 48 h of transfection,
total RNA was extracted from GC-2spd(ts) cells overexpressing
pcDNA3 (control) and the recombinant vectors pcDNA3_An-
tiTbca16. Semi-quantitative RT-PCR analysis showed a decrease
in the steady-state levels of Tbca13 mRNA whereas the Tbca16
transcript levels increase in comparison to control cells. In the
graphic normalized cDNA is expressed as a percentage of values
found in control cells transfected with pcDNA3. Values were
normalized with those of Hprt cDNA. Graphic bars show mean
values of two independent experiments.
(TIF)
Figure S2 Tbca16 knockdown by RNAi increases the
steady-state levels of TBCA protein in GC-2spd(ts)-
spermatocyte mouse cell line. After 48 h of transfection
soluble protein extracts were prepared from GC-2spd(ts) cells
expressing non-target shRNA, TbcashRNA (knockdown Tbca13
and Tbca16 RNAs) or Tbca16shRNA (to knockdown exclusively
the Tbca16 RNA) and analysed on a 16.5% (w/v) Tricine–SDS–
PAGE and probed with a polyclonal antibody against human
TBCA or a monoclonal against actin. Western blot analysis
showed a decrease in the steady-state levels of the TBCA protein
in Tbca shRNA expressing cells in comparison to those in cells
expressing non-target shRNA. However, in cells expressing Tbca16
shRNA, the steady-state levels of TBCA protein increases.
Normalized protein levels are expressed as a percentage of the
values found in cells expressing non-target shRNA (control cells).
Values were normalized with those of actin protein. Graphic bars
show mean values of two independent experiments.
(TIF)
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